$Candel Therapeutics (CADL.US)$ 27 institutions have been accumulating positions since September, with the latest one not yet announced. This stock will go up in the long term.

$Candel Therapeutics (CADL.US)$ This is my opinion, its Phase III study reached the main endpoint, which is a world of difference from Sava not reaching the endpoint. The survival rate of prostate cancer patients using their drug reached 70%. If true, it will not only be a victory for scientists, but also a victory for humanity in conquering prostate cancer. After FDA approval, the stock price will skyrocket. The current price drop due to fundraising is temporary, so buying on dips is the best strategy. In addition, many large institutions listed publicly have bought and held this month.

$Candel Therapeutics (CADL.US)$ Raising 80 million in an IPO to fund the next step, the stock price fell.

$Tesla (TSLA.US)$ Tesla's executives frequently sell Tesla's Stocks, who will be trapped by this?

$Tesla (TSLA.US)$ It's still too early for me to enter the market now, it hasn't bottomed out yet.

$Zapata Computing (ZPTA.US)$ Oh, this stock, both BlackRock and Bank of America hold their shares, now it has turned into a pile of waste paper.

$Cassava Sciences (SAVA.US)$ In a unilateral downtrend, no signs of a rebound have been seen.

$TSLA 270115 220.00P$ Please hurry up and fall, it's all up to you to make money.